49552 Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Notices 

week prior to each meeting at: http://

www.hhs.gov/paccarb. 

Members of the public will have the 

opportunity to provide comments live 

during the October meeting via 

conference line by pre-registering online 

at http://www.hhs.gov/paccarb. Preregistration is required for participation 

in this session with limited spots 

available. Written public comments can 

also be emailed to CARB@hhs.gov by 

midnight October 1, 2021 and should be 

limited to no more than one page. All 

public comments received prior to 

October 1, 2021, will be provided to 

Advisory Council members. 

Members of the public will have the 

opportunity to provide comments live 

during the November 30, 2021 and 

December 1, 2021 public meeting via 

conference line by pre-registering online 

at http://www.hhs.gov/paccarb. There 

will be two separate sessions available 

for public comment: An Innovation 

Spotlight will be held on November 30, 

2021 where companies and/or 

organizations involved in combating 

antibiotic resistance have an 

opportunity to present their work to 

members of the Advisory Council; and 

on December 1, 2021, where all 

members of the general public are 

welcome to provide oral comment 

during this separate session. Preregistration is required for participation 

in these sessions with limited spots 

available. Further information about 

these two sessions can be found online 

at http://www.hhs.gov/paccarb. Written 

public comments can also be emailed to 

CARB@hhs.gov by midnight November 

29, 2021 and should be limited to no 

more than one page. All public 

comments received prior to November 

29, 2021, will be provided to Advisory 

Council members. 

Dated: August 26, 2021. 

Jomana F. Musmar, 

Designated Federal Officer, Presidential 

Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant 

Secretary for Health. 

[FR Doc. 2021–19027 Filed 9–2–21; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Applications (P01 Clinical 

Trial Not Allowed). 

Date: September 27–28, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E70A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Soheyla Saadi, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3E70A, Rockville, MD 

20852, (240) 669–5178, saadisoh@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 31, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–19110 Filed 9–2–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health: 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Clinical Trials to Test the Effectiveness of 

Treatment, Preventive, and Services 

Interventions (R01, Collaborative R01, R34). 

Date: October 1, 2021. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Marcy Ellen Burstein, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6143, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–9699, 

bursteinme@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Early 

Phase Trials of Pharmacological and Device 

Based Interventions. 

Date: October 5, 2021. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Nicholas Gaiano, Ph.D., 

Review Branch Chief, Division of Extramural 

Activities, National Institute of Mental 

Health, NIH, Neuroscience Center/Room 

6150/MSC 9606, 6001 Executive Boulevard, 

Bethesda, MD 20892–9606, 301–443–2742, 

nick.gaiano@nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Pilot 

Effectiveness Trials of Interventions for 

Preschoolers with ADHD (R34). 

Date: October 5, 2021. 

Time: 12:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Rebecca Steiner Garcia, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6149, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–4525, 

steinerr@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; NonPharmacological Clinical Trials. 

Date: October 8, 2021. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Nicholas Gaiano, Ph.D., 

Review Branch Chief, Division of Extramural 

Activities, National Institute of Mental 

Health, NIH, Neuroscience Center/Room 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Notices 49553 

6150/MSC 9606, 6001 Executive Boulevard, 

Bethesda, MD 20892–9606, 301–443–2742, 

nick.gaiano@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: August 31, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–19109 Filed 9–2–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; National Institute of Allergy 

and Infectious Diseases (NIAID) Clinical Site 

Monitoring Center (CSMC). 

Date: September 9, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G53, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Konrad Krzewski, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G53, 

Rockville, MD 20852, 240–747–7526, 

konrad.krzewski@nih.gov. 

This notice is being published less 

than 15 days prior to the meeting due 

to the timing limitations imposed by the 

review and funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 31, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–19105 Filed 9–2–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2021–0030] 

Privacy Act of 1974; System of 

Records 

AGENCY: Office of the Immigration 

Detention Ombudsman, U.S. 

Department of Homeland Security. 

ACTION: Notice of a new system of 

records. 

SUMMARY: In accordance with the 

Privacy Act of 1974, the U.S. 

Department of Homeland Security 

(DHS) proposes to establish a new DHS 

system of records titled, ‘‘DHS/Office of 

the Immigration Detention Ombudsman 

(OIDO)–001 Office of the Immigration 

Detention Ombudsman System of 

Records.’’ This system of records allows 

DHS/OIDO to collect and maintain 

records related to cases brought forth by 

individuals or investigations regarding 

potential violations of law, individual 

rights, standards of professional 

conduct, contract terms, or policy 

related to immigration detention by any 

officer or employee of U.S. Customs and 

Border Protection (CBP) or U.S. 

Immigration and Customs Enforcement 

(ICE), or any contracted, subcontracted, 

or cooperating entity personnel. 

Additionally, DHS is issuing a Notice of 

Proposed Rulemaking to exempt this 

system of records from certain 

provisions of the Privacy Act, elsewhere 

in the Federal Register. This newly 

established system will be included in 

DHS’s inventory of record systems. 

DATES: Submit comments on or before 

October 4, 2021. This new system will 

be effective upon publication. Routine 

uses will be effective October 4, 2021. 

ADDRESSES: You may submit comments, 

identified by docket number DHS– 

2021–0030 by one of the following 

methods: 

• Federal e-Rulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Fax: 202–343–4010. 

• Mail: Lynn Parker Dupree, Chief 

Privacy Officer, Privacy Office, U.S. 

Department of Homeland Security, 

Washington, DC 20528–0655. 

Instructions: All submissions received 

must include the agency name and 

docket number DHS–2021–0030. All 

comments received will be posted 

without change to http://

www.regulations.gov, including any 

personal information provided. 

Docket: For access to the docket to 

read background documents or 

comments received, go to http://

www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: For 

general and privacy questions, please 

contact: Lynn Parker Dupree, (202) 343– 

1717, Privacy@hq.dhs.gov, Chief Privacy 

Officer, Privacy Office, U.S. Department 

of Homeland Security, Washington, DC 

20528–0655. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The U.S. Department of Homeland 

Security (DHS) Office of the 

Immigration Detention Ombudsman 

(OIDO) is giving notice that it proposes 

to establish a new DHS system of 

records notice (SORN) titled, ‘‘DHS/ 

OIDO–001 Office of the Immigration 

Detention Ombudsman System of 

Records.’’ OIDO is an independent 

component within DHS tasked with 

reviewing and resolving individual 

complaints and providing independent 

oversight of immigration detention 

facilities, including conducting 

announced and unannounced 

inspections, reviewing contract terms 

for immigration detention facilities and 

services, and making recommendations 

and reporting to Congress on findings. 

OIDO was established by Congress in 

Section 106 of the Consolidated 

Appropriations Act, 2020 (Pub. L. 116– 

93, 133 Stat. 2504 (Dec. 20, 2019), as 

codified by 6 U.S.C. 205, which 

outlined OIDO’s core responsibilities: 

• Establish and administer an 

independent, neutral, and confidential 

process to receive, investigate, resolve, 

and provide redress, including referral 

for investigation to the Office of 

Inspector General, referral to U.S. 

Citizenship and Immigration Services 

(USCIS) for immigration relief, or any 

other action determined appropriate, for 

cases in which Department officers or 

other personnel, or contracted, 

subcontracted, or cooperating entity 

personnel, are found to have engaged in 

misconduct or violated the rights of 

individuals in immigration detention; 

• Establish an accessible and 

standardized process regarding 

complaints against any officer or 

employee of U.S. Customs and Border 

Protection (CBP) or U.S. Immigration 

and Customs Enforcement (ICE), or any 

contracted, subcontracted, or 

cooperating entity personnel, for 

violations of law, standards of 


lotter on DSK11XQN23PROD with NOTICES1